Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8.56x is 99% above its 3-year average of -1038.24x, near the high end of its 3-year range (-9696.83x–5.58x).
19.37% above its 12-month average of -10.62x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3.15x.
INTEREST COVERAGE RATIO
-8.56x
INTEREST COVERAGE RATIO AVG TTM
-10.62x
INTEREST COVERAGE RATIO AVG 3Y
-1147.09x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+19.37%
CURRENT VS 3Y AVG
+99.25%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.45x
median of 435 covered companies
CURRENT VS SECTOR MEDIAN
-57.06%
vs the sector median at left
MacroGenics, Inc.
Market Cap
$235.50M
Interest Coverage Ratio
-8.56x
TTM Avg
-10.62x
3Y Avg
-1147.09x
5Y Avg
N/A
Market Cap
$237.22M
Interest Coverage Ratio
-133.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$237.69M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$233.22M
Interest Coverage Ratio
-3.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.78M
Interest Coverage Ratio
N/A
TTM Avg
0.97x
3Y Avg
1.45x
5Y Avg
67.07x
Market Cap
$241.89M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$241.56M
Interest Coverage Ratio
-1280.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.35M
Interest Coverage Ratio
-2.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.62M
Interest Coverage Ratio
0.57x
TTM Avg
0.57x
3Y Avg
0.57x
5Y Avg
0.57x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MacroGenics, Inc. (MGNX) | $235.50M | -8.56x | -10.62x | -1147.09x | N/A |
| BioAge Labs Inc. (BIOA)vs › | $237.22M | -133.11x | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | -1.08x | 0.39x | 0.39x | 0.20x |
| Biodesix, Inc. (BDSX)vs › | $233.22M | -3.60x | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.78M | N/A | 0.97x | 1.45x | 67.07x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $241.89M | 0.97x | 0.97x | 0.97x | 0.97x |
| InflaRx N.V. (IFRX)vs › | $241.56M | -1280.37x | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | -2.74x | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | 0.57x | 0.57x | 0.57x | 0.57x |
| Profound Medical Corp. (PROF)vs › | $226.52M | N/A | N/A | N/A | N/A |
Interest Coverage
-8.6x
Debt/Equity
0.82
Current Ratio
2.96
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3.15x |
| 2026-03-31 | -6.84x |
| 2025-12-31 | -2.83x |
| 2025-09-30 | 5.58x |
| 2025-06-30 | -45.83x |
| 2025-03-31 | -468.40x |
| 2024-06-30 | -9696.83x |
| 2024-03-31 | -47.44x |
| 2023-06-30 | -58.09x |
| 2023-03-31 | -58.58x |
